PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION
NEW YORK, May 23, 2025 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein”), a distinguished law firm with over 125 years of history, announces it is
investigating claims on behalf of investors of P3 Health Partners, Inc. (NASDAQ: PIII) (“P3” or the “Company”). (NASDAQ: PIII)
Allegations and Investigation Focus:
- The investigation seeks to determine whether P3 Health Partners, and certain officers and directors, made false and misleading statements or omissions in violation of the federal securities laws.
Triggering Events:
1. November 12, 2024 – P3 reported disappointing financial results in its Form 10-Q filed with the United States Securities and Exchange Commission (SEC):
- $15 million in negative adjusted EBITDA from a write-down of midyear risk adjustment receivables.
- Additional $10 million in expenses from negative medical claims developments.
- Another $10 million due to network and operating expenses.
- Management said it would exit underperforming relationships and reduce its provider network by 20%.
- The stock fell from $19.50 to $10.45, between November 12 and November 14, 2025, a decline of 46.4%.
2. March 28, 2025 – Annual Form 10-K disclosed:
- In June 2024, P3 received a civil investigative demand from the Department of Justice (DOJ).
- The inquiry relates to marketing practices and remuneration for Medicare Advantage brokers, agents, agencies and related third parties.
Why Wolf Haldenstein Adler Freeman & Herz LLP?
This illustrious firm, founded in 1888, is steadfast in their pursuit of justice for investors who have suffered financial harm due to these misrepresented statements. The law firm brings to the fore over 125 years of legal expertise in securities litigation and has a proven track record of protecting the rights of investors.
We encourage all investors who have been affected or have information that will assist in our investigation, to contact Wolf Haldenstein Adler Freeman & Herz LLP.
Contact Information:
Firm: Wolf Haldenstein Adler Freeman & Herz LLP
Primary Contact: Gregory Stone, Director of Case and Financial Analysis
Email: gstone@whafh.com or classmember@whafh.com
Phone: (800) 575-0735 or (212) 545-4774
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
- Viomi Receives NASDAQ Notice Related to Late Filing of Form 20-F - May 23, 2025
- Jayud Global Logistics Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency - May 23, 2025
- Oyster Enterprises II Acquisition Corp Completes Upsized $253,000,000 Initial Public Offering - May 23, 2025
